(Prof.) Dr. Linu Abraham Jacob - SPARSH Hospital
Contact Request for Callback

(Prof.) Dr. Linu Abraham Jacob

Lead Consultant - Medical Oncologist

Qualification:

MBBS , MD ( General Medicine) , DM (Medical Oncologist), ECMO , FRCP Edin, UICC Fellow

Years of Practice:

20

Specialities:

Oncology

Medical Oncology

Location:

SPARSH Hospital, Infantry Road

Languages Spoken:

English , Hindi , Kannada , Malayalam

Book an Appointment

(Prof.) Dr. Linu Abraham Jacob is available for appointments. Please fill the below form to book an appointment.

(Prof.)Dr. Linu Abraham Jacob is a senior Medical Oncologist with over 20 years of experience in the field of cancer care. He obtained his DM (Medical Oncology) training from the prestigious Kidwai Memorial Institute of Oncology, Bangalore. He did an observership at Mayo Clinic, Rochester, USA in the Division of Hematology as a visiting clinician and is a European Society of Medical Oncology (ESMO) certified Medical Oncologist. 

He is a Fellow of the American Cancer Society University (ACSU) and the Union International for Cancer Control (UICC). He has held  many senior academic roles in various medical institutions of the country like Medical College Trivandrum, Medical College Calicut and Kidwai Memorial Institute of Oncology Bangalore. As Professor & Head of Medical Oncology at Kidwai Memorial Institute of Oncology Bangalore, Dr. Jacob has contributed significantly to patient care, clinical research, and education. He pioneered initiatives like setting up bone marrow transplant unit and improving chemotherapy facilities, benefiting large number of underprivileged patients. 

He has guided and mentored many students, lead many multinational clinical trials and co-uthored over 200 publications. He is an editorial board member and peer reviewer to many academic journals and is the author and host of the “Chemolighthouse” mobile app on Play Store – a quick reference guide for chemotherapy protocols. Dr. Jacob’s dedication to improving oncology care won him a Certificate of recognition from Govt of Karnataka for his exemplary contributions. 

  • Breast Cancer
  • Ovarian Cancer
  • Colorectal Cancer
  • Lung Cancer
  • Head and Neck Cancer

  1. Jacob LA, Gupta A., et al. Accessibility to Rituximab and its impact on treatment outcomes in major Non-Hodgkin Lymphoma subtypes: Insights from a resource-limited setting. Medical Research Archives, [S.l.], v. 12, n. 9, sep. 2024. https://doi.org/10.18103/mra.v12i9.5791
  1. Jacob LA, Gupta A., et. al., 2024. The prognostic significance of CD10+ MUM1 + GCB subtype of Diffuse Large B-cell Lymphomas. Medical Research Archives, [online], 12(6). https://doi.org/10.18103/mra.v12i6.5412
  1. Choudhary A, Jacob L A, Babu S, et al. (March 16, 2024) Mortality Audit of Cancer Patients in the Department of Medical Oncology at a Tertiary Cancer Care Centre in South India. Cureus 16(3): e56296. https://doi.org/10.7759/cureus.56296
  1. Babu S, Choudhary A, Jacob L, et al. (March 10, 2024) Frequency of Programmed Death Receptor Ligand 1 Expression and Clinicopathological Factors Associated With Metastatic Triple-Negative Breast Cancer at a Tertiary Cancer Care Centre in South India. Cureus 16(3): e55880. https://doi.org/10.7759/cureus.55880
  1. Hegde AR, Jacob L, Babu S, Lokesh KN, Rudresh AH, Rajeev LK, Smitha CS. Acute infusion reactions occurring in a chemotherapy ward- a South Indian tertiary cancer center study. IJSR 2023; Volume 12 (issue 04).https://doi.org/10.36106/ijsr
  1. Shanthala S, Amirtham U, Lokesh KN, Jacob L, et al. Clinicopathological Evaluation of Patients with Hormone Receptor–Positive HER2-Negative Metastatic Breast Cancer Progressing on Endocrine Treatment: A Real-World Retrospective Study from a Regional Cancer Center in a Developing Country. South Asian J Cancer 2023;00(00):00–00. https://doi.org/10.1055/s-0043-1775806
  1. Shanthala S, Amirtham U, Gopal C, MN S, Jacob L, et al. Study of Biomarker Discordance between Primary and Recurrent Sites and its Clinical Implications in Metastatic Breast Cancer: A Single Institutional Study from India. South Asian J Cancer 2023;00(00):00–00. https://doi.org/10.1055/s-0043-1775807
  1. Rudresha AH, Hassan SA, Sreevalli A, Lokanatha D, Babu MCS, Lokesh KN, Rajeev LK, SaldanhaS, Thottian AGF, Sharma K and Jacob LA. Pre-phase strategy to mitigate frst cycle effect in difuse large B cell lymphoma. J Egypt Natl Canc Inst. 2022 May 9; 34(1):20. https://doi.org/10.1186/s43046-022-00116-5
  1. Goyal S, Jacob LA, Lokanatha D, Sureshbabu MC, Lokesh KN, Rudresha AH, Saldanha S, Amirtham U, Thottian AGF, Rajeev LK. Discordance in clinical versus pathological staging in breast cancer: Are we undermining the significance of accurate preoperative staging in the present era? Breast Dis. 2022; 41(1):115-121. https://doi.org/10.3233/BD-201029
  1. Pasha T, Krishna U, Loni R, Kumar A, Chandraraj V, Chavan P, Ashok S, Jacob LA et al. Long-term outcomes of reduced high-risk clinical target volume margin for intensity-modulated radiotherapy in locally advanced head and neck cancers. Middle East J Cancer. 2022; 13(4):665- https://doi.org/10.30476/mejc.2020. 86958.
  2. 1378 Govind KB, Koppaka D, Dasappa L, Jacob LA, C Babu SM, Lokesh NK, Haleshappa RA, Rajeev LK, Saldanha SC, Abhishek A, Asati V, Chethan R, Ramprasad VL. Detection of clinically relevant epidermal growth factor receptor pathway mutations in circulating cell-free tumor DNA using next generation sequencing in squamous cell carcinoma lung. South Asian J Cancer 2019; 8:247-https://doi.org/10.4103/sajc.sajc_281_18
  3. Babu KG, Chaudhuri T, Lakshmaiah KC, Dasappa L, Jacob LA, Suresh Babu MC, Rudresha AH, Lokesh KN, Rajeev LK. Modified Epirubicin, cisplatin, and 5-FU regimen as first-line chemotherapy in metastatic gastric or gastroesophageal junction adenocarcinoma: A Phase II study. South Asian J Cancer 2019; 8:85-87. https://doi.org/10.4103/sajc.sajc_146_18
  4. Kanakasetty GB, R C, K C L, Dasappa L, Jacob LA, M C SB, K N L, Haleshappa RA, L K R, Saldanha SC, Deepak K, Rajesh P, Asati V. Treatment patterns and comparative analysis of non-intensive regimens in elderly acute myeloid leukemia patients-a real-world experience from India. Ann Hematol 2019; 98:881-888. https://doi.org/10.1007/s00277-019-03600-6
  1. Suresh B, Asati V, Lakshmaiah KC, Babu G, Lokanatha D, Jacob LA, Lokesh KN, Rudresh AH, Rajeev LK, Smitha S, Anand A, Patidar R, Premalata CS. Primary gastrointestinal diffuse large B-cell lymphoma: A prospective study from South India. South Asian J Cancer 2019; 8:57-59.https://doi.org/10.4103/sajc.sajc_52_18
  1. Rudresha AH, Khandare PA, Lokanatha D, Linu AJ, Suresh Babu MC, Lokesh KN, Rajeev LK, Smitha CS, Amale VB, Premalata CS, Nikita M. HIV/AIDS-related lymphoma: perspective from a regional cancer center in India. Blood Res. 2019; 54:181-188. https://doi.org/10.5045/br.2019.54.3.181
  1. Lakshmaiah KC, Asati V, Babu KG, Lokanatha D, Jacob LA, Suresbabau MC, Lokesh KN, Rajeev LK, Rudresh AH, Saldanha S, Koppaka D, Patidar R, PremalataCS. Role of prephase treatment prior to definitive chemotherapy in patients with diffuse large B-cell lymphoma. Eur J Haematol 2018; 00:1–5. https://doi.org/10.1111/ejh.13068
  1. Lokesh KN, Anand A, Lakshmaiah KC, Babu KG, Lokanatha D, Jacob LA, Babu MCS, Rudresha AH, Rajeev LK, Saldanha SC, Giri GV, Panwar D, Koppaka D, Patidar R. Clinical profile and treatment outcomes of metastatic neuroendocrine carcinoma: A single institution experience. South Asian J Cancer 2018; 7:207-209. https://doi.org/10.4103/sajc.sajc_176_17
  1. Govind Babu K, Anand A, Lakshmaiah KC, Lokanatha D, Jacob LA, Suresh Babu MC, Lokesh KN, Rudresha HA, Rajeev LK, Saldanha SC, Giri GV, R C, Koppaka D, Panwar D, Kumar RV. Correlation of BMI with breast cancer subtype and tumour size. Ecancermedicalscience 2018 Jun 26; 12:845. https://doi.org/10.3332/ecancer.2018.845
  1. Babu Mc S, Anand A, Lakshmaiah KC, Babu K G, Lokanatha D, Jacob LA, Madhumathi DS, Lokesh KN, Rudresha AH, Rajeev LK, Patidar R. T-Cell Prolymphocytic Leukemia: An Experience from a Tertiary Cancer Centre in South India. Int J Hematol Oncol Stem Cell Res. 2018; 12:132-135. PMID: 30233775; PMCID: PMC6141430
  1. Babu KG, Chaudhuri T, Lakshmaiah KC, Dasappa L, Jacob LA, Suresh Babu MC, et al. Comparison of health-related quality of life with epirubicin, cisplatin plus 5-fluorouracil and docetaxel, cisplatin plus 5-fluorouracil chemotherapy regimens as first-line systemic therapy in locally advanced inoperable or metastatic gastric or gastroesophageal junction adenocarcinoma: A prospective study from South India. South Asian J Cancer 2018; 7:11-5. https://doi.org/10.4103/sajc.sajc_8_17
  1. Lokanatha D, Ananda A,Lakshmaiah KC, Babu KG, Jacob LA, Suresh Babu MC et al. Primary breast angiosarcoma – a single institution experience from a tertiary cancer center in South India. Breast Dis. 2018; 37:133-138. https://doi.org/10.3233/BD-170291
  1. Jacob LA, Lakshmaiah KC, Govindbabu K, Lokanatha D, Agarwal A, Anand A, Jaiswal SR, Addala V, Multani S. Genomic profiling of non-small cell lung cancer: A pilot study from South India. Int J Mol Immuno Oncol 2017; 2:63-66.https://doi.org/10.18203/issn.2456-3994
  1. Linu JA, Namratha Udupa MS, Madhumati DS, Lakshmaiah KC, Babu KG, Lokanatha D, Suresh Babu MC, Lokesh KN, Rajeev LK, RudreshaAH.Study of clinical, haematological and cytogenetic profile of patients with acute erythroid leukaemia. ecancer 2017; 11:712. https://doi.org/10.3332/ecancer.2017.712
  1. Kanakasetty GB, Kuntejowdahalli L, Thanky AH, Dasappa L, Jacob LA, Mallekavu SB, Kumari P. Predictive and Prognostic Implications of Variant Philadelphia Translocations in CML: Experience From a Tertiary Oncology Center in Southern India. Clinical Lymphoma, Myeloma & Leukemia 2017; 17:52-9. http://dx.doi.org/10.1016/j.clml.2016.09.007
  1. Kanakasetty GB, Thanky AH, Kuntegowdanahalli L, Dasappa L, Jacob L, Mallekavu SB, Lakkavalli R, Kadabur L, Antapura R. Can the Use of Bone Marrow Parameters Improve the Efficacy of Risk Prediction Scores in Chronic Myeloid Leukemia in Imatinib Era? Clin Lymphoma Myeloma Leuk. 2017; 17:375-381. https://doi.org/10.1016/j.clml.2017.02.029
  1. Lakshmaiah KC, Thanky AH, Lokanatha D, Govind Babu K, Jacob L, Babu S, Rudresha AH, Lokesh KN, Rajeev LK, Sridharmurthy A. Epidemiology and Outcomes with Platinum-Based Chemotherapy in Recurrent or Metastatic Carcinoma Cervix in a Developing Country: Experience from a Tertiary Oncology Centre in Southern India. Gulf J Oncolog. 2017; 1:20-26. PMID: 29019326
  1. Lakshmaiah KC, Anand A, Babu KG, Dasappa L, Jacob LA, Babu M C S, Lokesh KN, Rudresha AH, Rajeev LK, Saldanha SC, Giri GV, Koppaka D. Role of Taxanes in Triple-Negative Breast Cancer: A Study From Tertiary Cancer Center in South India. World J Oncol. 2017; 8:110-116. https://doi.org/10.14740/wjon1054w
  1. Haleshappa RA, Thanky AH, Kuntegowdanahalli L, Kanakasetty GB, Dasappa L, Jacob L. Epidemiology and outcomes of nasopharyngeal carcinoma: Experience from a regional cancer center in Southern India. South Asian J Cancer 2017; 6(3): 122–124.https://doi.org/10.4103/2278-330X.214578
  1. Suresh Babu MC, Chaudhuri T, Babu KG, Lakshmaiah KC, Lokanatha D, Jacob LA, Rudresha AH, Lokesh KN, Rajeev LK. Metastatic gastrointestinal stromal tumor: A regional cancer center experience of 44 cases. South Asian J Cancer 2017 Jul-Sep; 6(3): 118– 121.https://doi.org/10.4103/sajc.sajc_290_16
  1. Mallekavu SB, Thanky AH, Kanakasetty GB, Kuntegowdanahalli L, Dasappa L, Jacob LA. Prognostic significance of bone only metastasis compared to visceral metastasis in patients with carcinoma cervix treated with platinum-based chemotherapy. South Asian J Cancer 2017; 6:151-3.https://doi.org/10.4103/sajc.sajc_183_16
  1. Rudresha AH, Anand A, Lakshmaiah KC, Babu KG, Lokanatha D, Usha A, Jacob LAet
  2. Clinicopathological profile and treatment outcome of squamous cell carcinoma breast at a tertiary cancer center in South India. memo 2017; 10:259–262. https://doi.org/10.1007/s12254-017-0335-3
  1. Rudresha AH, Lakshmaiah KC, Agarwal A, Babu KG, Loknatha D, Jacob LA, et al. Plasmablastic lymphoma in immunocompetent and in immunocompromised patients: Experience at a regional cancer centre in India. South Asian J Cancer 2017; 6:69-71. https://doi.org/10.4103/sajc.sajc_186_16
  1. Kanakasetty GB, Dasappa L, Lakshmaiah KC, Kamath M, Jacob LA, Mallekavu SB et al. Clinicopathological Profile of Pure Neuroendocrine Neoplasms of the Esophagus: A South Indian Center Experience. Journal of Oncology, Volume 2016, Article ID 2402417, 6 pages. http://dx.doi.org/10.1155/2016/2402417
  1. Sinha M, Rao CR, Shafiulla M, Shankaranand B, Viveka BK, Lakshmaiah KC, Jacob LA, Babu GK, Jayshree RS. Plasma Epstein Barr viral load in adult-onset Hodgkin lymphoma in South India. Hematol Oncol Stem Cell Ther 2016; 9:8–13. http://dx.doi.org/10.1016/j.hemonc.2015.11.004
  1. Babu G, Saldanha SC, Chinnagiriyappa LK, Jacob LA, Mallekavu SB, Dasappa L, et al. The Efficacy, Safety, and Cost Benefit of Olanzapine versus Aprepitant in Highly Emetogenic Chemotherapy: A Pilot Study from South India. Chemotherapy Research and Practice Volume 2016, Article ID 3439707, 5 pages. http://dx.doi.org/10.1155/2016/3439707
  1. Babu G, Das U, Lakshmaiah K, Dasappa L, Jacob LA, Babu S. Aflibercept as a second-line therapy in metastatic colorectal cancer: A limited Indian experience. J Sci Soc 2016; 43:140- 3.https://doi.org/10.4103/0974-5009.190538
  1. Dasappa L, Babu G, Chennagiriyappa LK, Appaji L, Pramod K, Amirtham U, Jacob LA et al. Primary intracranial germ cell tumors: A single institution experience from a South Indian tertiary cancer center. Clin Cancer Investig J 2016; 5:299-304. https://doi.org/10.4103/2278-0513.186099
  1. Abraham LJ, Saldanha SC, Kuntegowdanahalli LC, Bharatnur S, Dasappa L, Babu G, Babu MS, Kiran PR. Hairy cell leukemia – clinical profile and treatment outcome from a Tertiary Regional Cancer Institute in South India. Clin Cancer Investig J 2016; 5:141-5. https://doi.org/10.4103/2278-0513.176254
  1. Babu S, Amirtham U, Lokesh KN, Babu KG, Lakshmaiah KC, Dasappa L, Premalata CS, Jacob LA, Rudresh AH, Rajeev LK, Arroju V. Ovarian Non-Hodgkin’s Lymphoma from a Regional Cancer Centre in South India. International Journal of Sciences 2016;5: 31-35. http://www.ijsciences.com/pub/issue/2016-05/
  1. Jacob LA, Aparna S, Lakshmaiah KC, Lokanatha D, Babu G, Babu S, Appachu S. Decitabine Compared with Low-Dose Cytarabine for the Treatment of Older Patients with Newly Diagnosed Acute Myeloid Leukemia: A Pilot Study of Safety, Efficacy, and Cost-Effectiveness. Advances in Hematology, vol. 2015, Article ID 167029, 6 pages. http://dx.doi.org/10.1155/2015/167029
  1. Lakshmaiah KC, Rachan Shetty KS, SathyanarayananV, Lokanatha D, Abraham LJ, Babu KG. Lenalidomide in relapsed refractory non-Hodgkin’s lymphoma: An Indian perspective. J Can Res Ther 2015; 11:857-61. https://doi.org/10.4103/0973-1482.151418
  1. Babu GK, Thanky A, Jacob LA, Suresh Babu MC, Dasappa L, Ganguly S. Outcome of young adults with chronic myeloid leukemia treated with upfront imatinib: A single institutional experience. J Appl Hematol 2015; 6:157-61. https://doi.org/10.4103/1658-5127.171987
  1. Babu KG, Lakshmaiah KC, Lokanatha D, Babu MS, Sathyanarayanan V, Suresh TM, Rao CR, Premalata CS, Abraham LJ, Lokesh KN, Sirsath NT. Diffuse large B-cell lymphoma of the thyroid: Seven cases with review of the literature from India. Onc Gas Hep Rep 2015; 4:81-4. https://doi.org/10.4103/2348-3113.152321
  1. Das U, Lakshmaiah KC, Govind Babu K, Suresh TM, Lokanatha D, Jacob L, Babu S. The actual scenario of neoadjuvant chemotherapy of breast cancer in developing country: a report of 80 cases of breast cancer from a tertiary cancer centre in India. J Cancer Res Clin Oncol 2014; 140(10):1777-82. https://doi.org/10.1007/s00432-014-1724-1
  1. Lakshmaiah KC, Das U, Suresh TM, Lokanatha D, Babu GK, Jacob LA, Babu S. A Study of Triple Negative Breast Cancer at a Tertiary Cancer Care Center in Southern India. Ann Med Health Sci Res 2014; 4: 933–7. https://doi.org/10.4103/2141-9248.144917
  1. Lakshmaiah KC, Sathyanarayanan V, Babu K G, Lokanatha D, Lokesh KN, Babu MC, Rao CR, Premalatha CS, Suresh TM, Unnikrishnan V, Abraham LJ. Primary central nervous system lymphoma: An Indian Perspective. Clin Cancer Investig J 2014; 3:514-20. https://doi.org/10.4103/2278-0513.142642
  1. Lakshmaiah KC, Lokesh KN, Sathyanarayanan V, Premalatha CS, Rao CR, Suresh TM, Babu KG, Lokanatha D, Jacob LA, Babu S. Extranodal diffuse large B-cell lymphoma: Experience from a tertiary care oncology center in South India. Clin Cancer Investig J 2014; 3:276-80. https://doi.org/10.4103/2278-0513.134468
  1. Lakshmaiah KC, Suresh TM, Babu G, Babu S, Purohit S, Guruprasad B, Jacob L, Loknath D. Gastrointestinal stromal tumors: A single institute experience from South India. Clin Cancer Investig J 2014; 3:62-5. https://doi.org/10.4103/2278-0513.125797
  1. Babu KG, Suresh Babu MC, Abraham LJ, Suresh TM, Dasappa L, Sirsath NT, Lakshmaiah KC. Plasmablastic lymphoma: Does prognosis differ with HIV status and site of disease? Onc Gas Hep Rep 2014; 3:25-9. https://doi.org/10.4103/2348-3113.134211
  1. Lakshmaiah KC, Guruprasad B, Shah A, Kavitha S, Abraham LJ, Govindbabu K, Aruna kumariBS, Appaji L. Anaplastic large cell lymphoma: a single institution experience from India. J Cancer Res Ther 2013; 9(4):649-52. https://doi.org/10.4103/0973-1482.126468
  1. Lakshmaiah KC, Bhise R, Purohit S, Abraham LJ, Lokanatha D, Suresh TM, Appaji L, Arunakumari BS, Govindbabu K. Chronic myeloid leukemia in children and adolescents: results of treatment with imatinib mesylate. Leukemia & Lymphoma 2012; 53(12): 2430-33. https://doi.org/10.3109/10428194.2012.694076
  1. Attili SVS, Dadhich HK, Jacob LA, Anupama G, Bapsy PP, Devi L, Sundereshan TS, Babu GK, Loknath D. A retrospective study of clinico-hematological and cytogenetic profile of erythroleukemia from South India. Turk J Hematol 2006; 23:158-163. PMID: 27265484.

Review articles:

  1. Lakshmaiah KC, Jacob LA, Aparna S, Lokanatha D, Saldanha SC. Epigenetic therapy of cancer with histone deacetylase inhibitors. J Can Res Ther 2014; 10:469-78. https://doi.org/10.4103/0973-1482.137937
  1. Babu KG, Lakshmaiah KC, Sirsath NT, Dasappa L, Jacob LA, Babu S. Neurocognitive effects of cancer: a new surrogate end point. Int J Health Sci Res. 2014; 4(4):166-179. ISSN: 2249-9571
  1. Guruprasad B, Jacob LA. Mucinous cystadenocarcinoma of ovary: Changing treatment paradigms. World J ObstetGynecol 2012;1: 42-45. [DOI: 10.5317/wjog.v1.i4.42 Breif communications & case reports:
    1. Dayanand SP, Linu AJ, et al., 2024. The Unusual Sequence of Lymphomatoid Papulosis Following Hodgkin’s Disease: A Case Report. Medical Research Archives, [online] 12(6). https://doi.org/10.18103/mra.v 12i6.0000
    1. Jacob LA. A Rare Case Report of Synchronous Multiple Myeloma and Chronic Myeloid Leukemia, aDiagnostic and Therapeutic Dilemma. Clin Case Rep Int. 2022; 6: 1392. http://clinicalcasereportsint.com/
    1. Abraham LJ, Rudresha AH, Saldanha SC, Koppaka D, Kuntegowdanahalli LC, Dasappa L, Kiran PR. Gemcitabine-induced supraventricular tachycardia: A rare manifestation. Clin Cancer Investig J 2016; 5:200-2. https://doi.org/10.4103/2278-0513.178064
    1. Dasappa L, Saldanha SC, Kuntegowdanahalli LC, Jacob LA, Babu G, Babu MS, et al. An unusual presentation of cardiac metastasis in breast cancer. Clin Cancer Investig J 2016; 5:89-91. https://doi.org/10.4103/2278-0513.173258
    1. Babu G, Saldanha SC, Babu MS, Kuntegowdanahalli LC, Rajeev LK, Lokesh KN, Dasappa L, Jacob LA, Haleshappa RA. Breast cancer as second malignant neoplasm after acute myeloid leukemia: A rare occurrence. Clin Cancer Investig J 2016; 5:333-5. https://doi.org/10.4103/2278-0513.186105
    1. Kuntegowdenahalli LC, Jacob LA, Komaranchath AS, Amirtham U. A rare case of primary anaplastic large cell lymphoma of the central nervous system. J Can Res Ther 2015; 11:943-5. https://doi.org/10.4103/0973-1482.162115
    1. Ganguly S, Jacob LA, Biswas S, Lakshmaiah KC. Pancreatic neuroendocrine tumor in an individual with Von Hippel Lindau syndrome. A case report and review literature. Int J Cancer Ther Oncol 2015; 3:3410. 10.14319/ijcto.34.10
    1. Komaranchath AS, Rudresh AH, Lakshmaiah K C, Premalata CS, Lok;natha D, Jacob LA. Unicentric Castleman’s disease: An unusual cause of neck swelling. J Case Rep Images Oncology 2015; 1:5– https://doi.org/10.5348/Z10-2015-2-CR-2
    1. C LK, V GG, Sirsath NT, Dasappa L, Babu KG, Jacob LA. Follicular Lymphoma Presenting with Skeletal Metastasis. IJHSR. 2014; 4(7): 262-265. ISSN: 2249-9571
    1. Lokesh KN, Sathyanarayanan V, Lakshmaiah KC, Suresh TM, Lokanatha D, Babu KG, Jacob LA, Babu S. Primary breast lymphoma in males – a report of two cases with a review of the literature. Ecancermedicalscience 2013; 7:347. https://doi.org/10.3332/ecancer.2013.347
    1. Lakshmaiah KC, Saini KS, Singh T, Jain A, Kumar RV, Sajeevan KV, Lokanatha D, Jacob LA. Primary Synovial Sarcoma of Kidney – A report of 2 cases and review of Literature. Journal of the Egyptian Nat. Cancer Inst., 2010; 22(3): 149-53
    1. Singh T, Satheesh CT, Lakshmaiah KC, Suresh TM, Babu GK, Lokanatha D, Jacob LA, RajashekarHalkud. Primary bone lymphoma: A report of two cases and review of the literature. Journal of Cancer Research and Therapeutics, 2010; 6(3): 296-8. https://doi.org/10.4103/0973-

Our Doctors

Unlock the door to exceptional healthcare, book an appointment with SPARSH Hospital and let your journey to wellness begin.